Navidea Biopharmaceuticals is the older company (1983 vs 1996); Philogen S.p.A. is the larger of the two.
Side-by-Side Comparison
| Metric | Navidea Biopharmaceuticals | Philogen S.p.A. |
|---|---|---|
| Founded | ||
| Founded | 1983 older | 1996 |
| Headquarters | ||
| Headquarters | Dublin, United States | Sovicille, Italy |
| Employees | ||
| Employees | 9 | 184 larger |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health Care | Biotechnology, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Post Ipo Equity | IPO |
| Total Funding | ||
| Total Funding | $133.75M | $130.84M |
| Funding Rounds | ||
| Funding Rounds | 8 | 2 |
| Services | ||
| Services | Not tracked yet | Innovative cancer treatment development, Therapeutic and imaging radio conjugate production, Scientific research and drug development |
| Target Customers | ||
| Target Customers | Not tracked yet | Medical professionals, Pharmaceutical companies, Cancer treatment centers, Healthcare providers, Research institutions |
| Taxonomy | ||
| Taxonomy | Not tracked yet | Biopharmaceuticals, Angiogenesis, Monoclonal Antibodies, Cancer Therapy, Rheumatoid Arthritis Treatment, Age-related Macular Degeneration, Tumor Neo-vasculature Targeting, Antibody Derivatives, Clinical Trials, GMP Production, R&D, Patent Portfolio, Pharmaceutical Partnerships, Biotechnology Innovator |
| Website | ||
| Website | navidea.com | philogen.com |
About Navidea Biopharmaceuticals
Navidea Biopharmaceuticals is a US-based company founded in 1983, focused on precision medicine and immuno-targeted products for identifying disease pathways. Using its Manocept™ technology, the company aims to develop targeted diagnostics and therapies for cancer, autoimmune conditions, and inflamm...
About Philogen S.p.A.
Philogen S.p.A., founded in 1996, is a Swiss-Italian biotechnology company with a focus on developing advanced biopharmaceuticals aimed at treating disorders related to angiogenesis. Angiogenesis, the formation of new blood vessels, is a process commonly found in severe conditions like cancer, rheum...
We will tell you when either one moves
BounceWatch watches Navidea Biopharmaceuticals and Philogen S.p.A. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Navidea Biopharmaceuti... and Philogen S.p.A. — by email.
Frequently Asked Questions
Compare Navidea Biopharmaceuticals with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Navidea Biopharmaceuticals on 15 Sep 2024, and Philogen S.p.A. on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
